{"title":"Reduced doses of direct oral anticoagulation are safe in atrial fibrillation patients with mild thrombocytopenia","authors":"M. Gross","doi":"10.22237/CRP/1567555920","DOIUrl":"https://doi.org/10.22237/CRP/1567555920","url":null,"abstract":"<p>Janion-Sadowska A, Papuga-Szela E, Łukaszuk R, Chrapek M, Undas A. Non–Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia. <em>Journal of Cardiovascular Pharmacology</em>, 2018;72(3):153-160. doi: <a href=\"https://doi.org/10.1097/FJC.0000000000000607\">10.1097/FJC.0000000000000607</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81212962","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Fecal microbiota therapy in recurrent and refractory clostridium difficile infections has been associated with positive results in immunocompromised patients","authors":"Eric Applebach","doi":"10.22237/CRP/1567555800","DOIUrl":"https://doi.org/10.22237/CRP/1567555800","url":null,"abstract":"<p>A critical appraisal and clinical application of Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. <em>The American Journal of Gastroenterology</em>, 2014;<em>109</em>(7):1065-71. doi: <a href=\"https://doi.org/10.1038/ajg.2014.133\">10.1038/ajg.2014.133</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73933712","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Intravenous iodinated contrast is not associated with acute kidney injury in adult patients with nephrotic syndrome","authors":"A. Bacyinski","doi":"10.22237/crp/1567555740","DOIUrl":"https://doi.org/10.22237/crp/1567555740","url":null,"abstract":"<p>A critical appraisal and clinical application of Tao SM, Kong X, Schoepf UJ, et al. Acute kidney injury in patients with nephrotic syndrome undergoing contrast-enhanced CT for suspected venous thromboembolism: a propensity score-matched retrospective cohort study. <em>European Radiology</em>. 2018;28(4):1585-1593. doi: <a href=\"https://doi.org/10.1007/s00330-017-5109-0\">10.1007/s00330-017-5109-0</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"91130359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Weighing harms, benefits, and alternatives for a young man with a recent flare of ulcerative colitis","authors":"L. Welsh","doi":"10.22237/crp/1567555620","DOIUrl":"https://doi.org/10.22237/crp/1567555620","url":null,"abstract":"<p>A critical appraisal and clinical application of Sandborn WJ, Su C, Sands B, et al. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis. <em>N Engl J Med</em>. 2017 May 4;376(18):1723-1736. doi: <a href=\"https://doi.org/10.1056/NEJMoa1606910\">10.1056/NEJMoa1606910</a></p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84407961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Thrombosis prevention in atrial fibrillation with concomitant cirrhosis: oral anticoagulation may not be worth the risks","authors":"Madeline Berschback","doi":"10.22237/CRP/1567555560","DOIUrl":"https://doi.org/10.22237/CRP/1567555560","url":null,"abstract":"<p>A critical appraisal and clinical application of Kuo L, Chao TF, Liu CJ, et al. Liver cirrhosis in patients with atrial fibrillation: Would oral anticoagulation have a net clinical benefit for stroke prevention? <em>J Am Heart Assoc</em>. 2017;6(6):e005307. doi: <a href=\"https://doi.org/10.1161/jaha.116.005307\">10.1161/jaha.116.005307</a> </p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89587639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Carvedilol is not superior to metoprolol for heart failure patients when given at equivalent doses","authors":"A. Gorman","doi":"10.22237/CRP/1567555680","DOIUrl":"https://doi.org/10.22237/CRP/1567555680","url":null,"abstract":"<p>A critical appraisal and clinical application of Lazarus DL, Jackevicius CA, Behlouli H, et al. Population-Based Analysis of Class Effect of β Blockers in Heart Failure. <em>The American Journal of Cardiology </em>2011;107(8):1196-1202. doi: <a href=\"https://doi.org/10.1016/j.amjcard.2010.12.017\">10.1016/j.amjcard.2010.12.017</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90574544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"High-dose finasteride is an effective treatment modality for androgenic alopecia in postmenopausal women","authors":"Joshua Gaudette","doi":"10.22237/CRP/1567555440","DOIUrl":"https://doi.org/10.22237/CRP/1567555440","url":null,"abstract":"<p>A critical appraisal and clinical application of Oliveira-Soares R, Silva JE, Correia M, André M. Finasteride 5 mg/day treatment of patterned hair loss in normo-androgenetic postmenopausal women. <em>International Journal of Trichology</em>. 2013;5(1):22-25. doi: <a href=\"https://doi.org/10.4103/0974-7753.114709\">10.4103/0974-7753.114709</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89684075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Andexanet alfa is an effective reversal agent for factor Xa inhibitors in patients that develop intracranial hemorrhage","authors":"J. Friedli","doi":"10.22237/CRP/1567555500","DOIUrl":"https://doi.org/10.22237/CRP/1567555500","url":null,"abstract":"<p>A critical appraisal and clinical application of Connolly SJ, Milling TJ, Eikelboom JW, et al. Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. <em>N Engl J Med</em>. 2016;375(12):1131-1141. doi: <a href=\"https://doi.org/10.1056/NEJMoa1607887\">10.1056/NEJMoa1607887</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72616630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cannabidiol is beneficial in management of drug-resistant Dravet syndrome","authors":"Nikita Desai","doi":"10.22237/CRP/1567555380","DOIUrl":"https://doi.org/10.22237/CRP/1567555380","url":null,"abstract":"<p>A critical appraisal and clinical application of Devinsky O, Cross H, Laux L, et al. Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. <em>N Engl J Med</em>. 2017;376(21):2011-2020. doi: <a href=\"https://doi.org/10.1056/NEJMoa1611618\">10.1056/NEJMoa1611618</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77031946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Agenesis of the corpus callosum is associated with developmental delay and intellectual disability","authors":"Quinton J. Mandle","doi":"10.22237/CRP/1567555260","DOIUrl":"https://doi.org/10.22237/CRP/1567555260","url":null,"abstract":"<p>A critical appraisal and clinical application of Romaniello R, Marelli S, Giorda R, et al. Clinical characterization, genetics, and long-term follow-up of a large cohort of patients with agenesis of the corpus callosum. <em>Journal of Child Neurology</em>, 2016;32(1):60-71. doi: <a href=\"https://doi.org/10.1177/0883073816664668\">10.1177/0883073816664668</a>.</p>","PeriodicalId":10422,"journal":{"name":"Clinical Research In Practice: The Journal of Team Hippocrates","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82824354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}